Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar 125001, India.
J Enzyme Inhib Med Chem. 2009 Oct;24(5):1161-8. doi: 10.1080/14756360802694427.
In the present study we have synthesized (4-nitrophenyl)-[2-(substituted phenyl)-benzoimidazol-1-yl]-methanones, (2-bromophenyl)-[2-(substituted phenyl)-benzoimidazol-1-yl]-methanone analogues (1-14) and evaluated them for their antimicrobial and antiviral potential. The results of antimicrobial screening indicated that none of the synthesized compounds were effective against the tested bacterial strains. Compounds 3, 11, 13 and compounds 5, 11, 12 were found to be active against Aspergillus niger and Candida albicans respectively, and may be further developed as antifungal agents. Furthermore, evaluation against a panel of different viruses pointed out the selective activity of compounds 5 and 6 against vaccinia virus and Coxsackie virus B4.
在本研究中,我们合成了(4-硝基苯基)-[2-(取代苯基)-苯并咪唑-1-基]-甲酮和(2-溴苯基)-[2-(取代苯基)-苯并咪唑-1-基]-甲酮类似物(1-14),并评估了它们的抗菌和抗病毒潜力。抗菌筛选结果表明,所合成的化合物均对测试的细菌菌株没有效果。化合物 3、11、13 和化合物 5、11、12 分别对黑曲霉和白色念珠菌表现出活性,可能进一步开发为抗真菌剂。此外,对一系列不同病毒的评估指出,化合物 5 和 6 对牛痘病毒和柯萨奇病毒 B4 具有选择性活性。